Jakafi 25 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FCZC0
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,379
Award facts
- Contract value 100% obligated
- $12,378.73 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $12,378.73 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 60 tablets of Jakafi 25 mg. The award, issued on December 15, 2025, with an ultimate completion date of December 16, 2025, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group will perform this delivery order at its headquarters location in Park Ridge, Illinois.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to provide recurring pharmaceutical and medical consumable supplies to Department of Defense healthcare facilities worldwide. The underlying IDC, designated SPE2DR and valued at $499,999,999, was awarded on November 13, 2025, and includes a 30-month base period with three 30-month option periods extending through December 31, 2036. DMS Pharmaceutical Group's established performance across numerous delivery orders for diverse pharmaceutical products, including branded and generic medications, biologics, and specialty pharmaceuticals, demonstrates its capability to serve as a critical supplier within the federal military medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FCZC0?
SPE2DR26FCZC0 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 15, 2025.
How much is contract SPE2DR26FCZC0 worth?
The government has obligated $12,379 on SPE2DR26FCZC0.
Is contract SPE2DR26FCZC0 an order under another contract?
Yes. SPE2DR26FCZC0 is a delivery order under SPE2DR25D9127, an indefinite delivery contract.
Was contract SPE2DR26FCZC0 competed?
The extent of competition for SPE2DR26FCZC0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award